AIDS-defining illnesses

NEW YORK, July 24 (Praxis Press) The introduction of highly active antiretroviral therapy (HAART) may have altered clinical patterns of HIV-related diseases. Mocroft and colleagues studied the incidence and types of AIDS-defining illnesses (ADIs) in European outpatient clinics between 1994 (pre-HAART) and 1998 (post-HAART). The incidence of ADIs declined significantly, and rates of ADIs were lower among patients receiving HAART for all CD4-cell strata. Non-Hodgkin lymphoma became one of the most

July 25, 2000

NEW YORK, July 24 (Praxis Press) The introduction of highly active antiretroviral therapy (HAART) may have altered clinical patterns of HIV-related diseases. Mocroft and colleagues studied the incidence and types of AIDS-defining illnesses (ADIs) in European outpatient clinics between 1994 (pre-HAART) and 1998 (post-HAART). The incidence of ADIs declined significantly, and rates of ADIs were lower among patients receiving HAART for all CD4-cell strata. Non-Hodgkin lymphoma became one of the most common ADIs. Although HAART has decreased the incidence of ADIs, physicians are likely to encounter previously uncommon types of ADIs.

Popular Now

  1. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. Consilience, Episode 3: Cancer, Obscured
  4. A History of Screening for Natural Products to Fight Cancer
AAAS